Study reveals how melanoma outmaneuvers both drugs and immune defenses

Дата публикации: 22-10-2026 20:20:13

Melanoma is one of the most difficult cancers to treat due to its resistance to targeted drug therapies. But a new study from the University of Kentucky Markey Cancer Center shows that the cancer is playing offense as well as defense: In addition to forming resistance against the MAPK inhibitors that are commonly used to treat it, the cancer also actively suppresses the immune cells that would otherwise help eliminate it.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning	0	9.7	22-10-2026
2	New study reveals how blood cancers outsmart BTK-targeted therapies	0	8.1	28-07-2026
3	Researchers show how leukemia cells 'hide' from treatment	0	9.92	23-10-2026
4	Ученые выяснили, как остановить развитие меланомы	0	0	04-01-2019
5	Lab-grown tumors reveal immune cells capable of killing small cell lung cancer	0	7.57	15-10-2026
6	New experimental approach may help overcome drug resistance in deadly brain cancer	5	8	09-07-2026
7	Tumors hijack macrophages after they clear dead cells, real-time tracking reveals	0	8	02-07-2026
8	Studies help explain why some prostate cancers become resistant to hormone therapy	2	8	04-12-2023
9	Inside the rise of lung cancer in non-smokers... and why a diagnosis is not the death sentence it once was if you spot the subtle symptoms early enough	0	9.31	15-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 5.31. Источник: medicalxpress.com.